Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000884065-97-000001
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
14
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 NEUREX CORPORATION FORM 10-K 10-K 265225
2 WARNER LAMBERT AGREEMENT EX-10 12047
3 CONSULTANT AGREEMENT WITH PLEXUS VENTURES EX-10 16951
4 CONSULTANT AGREEMENT WITH PLEXUS VENTURES EX-10 20687
5 JOHN AMES PROMISSORY NOTE EX-10 4234
6 JOHN AMES PROMISSORY NOTE EX-10 4508
7 AGREEMENT WITH BEAUFOUR IPSON EX-10 101426
8 MALLINCKRODT AGREEMENT EX-10 46001
9 LEASE AGREEMENT EX-10 119566
10 COMPUATION OF NET LOSS PER SHARE EX-11 1665
11 LIST OF SUBSIDIARIES EX-21 208
12 CONSENT OF INDEPENDENT AUDITORS EX-23 830
13 FDS -- EX-27 2431
14 PRESS RELEASE EX-99 1478
  Complete submission text file 0000884065-97-000001.txt   599922
Mailing Address
Business Address 3760 HAVEN AVE MENLO PARK CA 94025-1012 4158531500
NEUREX CORP/DE (Filer) CIK: 0000884065 (see all company filings)

EIN.: 770128552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-96840 | Film No.: 97568557
SIC: 2836 Biological Products, (No Diagnostic Substances)